Pulsenmore Expands Home Ultrasound for Pregnancy Care
Ramat Gan, Israel, August 19, 2026 Pulsenmore Ltd. announced the expansion of its home ultrasound activities in Israel following...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Ramat Gan, Israel, August 19, 2026 Pulsenmore Ltd. announced the expansion of its home ultrasound activities in Israel following...
SALT LAKE CITY, Utah, July 21, 2026 Myriad Genetics has officially launched the FirstGene® Multiple Prenatal Screen, introducing what...
SALT LAKE CITY | July 9, 2026 Sera Prognostics Inc., a leader in precision pregnancy diagnostics, has announced the...
SALT LAKE CITY, June 23, 2026 Sera Prognostics Inc. welcomed new legislative action in Illinois that expands Medicaid coverage...
